Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation. (Q38060357)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation. |
scientific article |
Statements
Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation (English)
Yvette van Kooyk
Wendy W J Unger
Cynthia M Fehres
14 November 2012